Literature DB >> 23708959

Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk.

Hongtuan Zhang1, Andi Wang, Hui Ma, Yong Xu.   

Abstract

Epidemiological studies investigating the association between the insulin receptor substrate 1 (IRS1) gene Gly972Arg (rs1801278) polymorphism and various carcinomas risk reported conflicting results. Thus, a systemic review and meta-analysis of published studies were performed to assess the possible association. A comprehensive search was conducted to identify all eligible studies of IRS1 Gly972Arg polymorphism and cancer risk. Odds ratios (ORs) and 95 % confidence intervals (CIs) were used to assess the strength of the associations. A total of 16 independent studies, including 11,776 cases and 11,654 controls, were identified. When all studies were pooled, we found a significant association between IRS1 Gly972Arg polymorphism and increased cancer risk under dominant model (OR = 1.16, 95 %CI = 1.04-1.30, P = 0.007) and allelic model (OR = 1.16, 95 %CI = 1.02-1.30, P = 0.02). In subgroup analysis based on cancer type, increased cancer risk was found in ovarian cancer (dominant: OR = 1.55, 95 %CI = 1.17-2.05, P = 0.002; allelic: OR = 1.55, 95 %CI = 1.19-2.01, P = 0.001), breast cancer (allelic: OR = 1.12, 95 %CI = 1.00-1.26, P = 0.05), and other cancers (allelic: OR = 1.31, 95 %CI = 1.00-1.71, P = 0.05). When stratified by study types, significant associations were observed in both cohort studies (dominant: OR = 1.25, 95 %CI = 1.06-1.47, P = 0.007; allelic: OR = 1.25, 95 %CI = 1.07-1.46, P = 0.005) and case-control studies (dominant: OR = 1.15, 95 %CI = 1.01-1.31, P = 0.04). In the subgroup analyses by ethnicity, significantly increased cancer risk was suggested among both Caucasians (dominant: OR = 1.13, 95 %CI = 1.02-1.26, P = 0.02; allelic: OR = 1.13, 95 %CI = 1.03-1.25, P = 0.01) and mixed population (dominant: OR = 1.22, 95 %CI = 1.01-1.46, P = 0.04). Our investigations demonstrate that IRS1 Gly972Arg polymorphism was associated with an increased risk of cancer, and additional well-designed studies are warranted to validate these findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708959     DOI: 10.1007/s13277-013-0855-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  Meta-analysis of genetic association studies.

Authors:  Marcus R Munafò; Jonathan Flint
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

2.  Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.

Authors:  M L Slattery; C Sweeney; R Wolff; J Herrick; K Baumgartner; A Giuliano; T Byers
Journal:  Breast Cancer Res Treat       Date:  2006-10-19       Impact factor: 4.872

3.  Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.

Authors:  Andrea Saracevic; Nora Nikolac; Ante Reljic; Ana-Maria Simundic
Journal:  Genet Test Mol Biomarkers       Date:  2011-01-04

4.  Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.

Authors:  Xiaoqun Dong; Yanan Li; Hongwei Tang; Ping Chang; Kenneth R Hess; James L Abbruzzese; Donghui Li
Journal:  Cancer Epidemiol       Date:  2011-08-17       Impact factor: 2.984

5.  PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).

Authors:  Martha L Slattery; Karen Curtin; Roger Wolff; Khe Ni Ma; Carol Sweeney; Maureen Murtaugh; John D Potter; Theodore R Levin; Wade Samowitz
Journal:  Cancer Causes Control       Date:  2006-04       Impact factor: 2.506

6.  No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.

Authors:  K Fall; J R Stark; L A Mucci; J Chan; M J Stampfer; T Kurth; P G Febbo; P Kantoff; J Ma
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

7.  The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer.

Authors:  Kerstin Wagner; Kari Hemminki; Ewa Grzybowska; Rüdiger Klaes; Dorota Butkiewicz; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Danuta Mielzynska; Ewa Siwinska; Asta Försti
Journal:  Carcinogenesis       Date:  2004-08-12       Impact factor: 4.944

8.  A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.

Authors:  Yuan C Ding; Lesley McGuffog; Sue Healey; Eitan Friedman; Yael Laitman; Shani- Paluch-Shimon; Bella Kaufman; Annelie Liljegren; Annika Lindblom; Håkan Olsson; Ulf Kristoffersson; Marie Stenmark-Askmalm; Beatrice Melin; Susan M Domchek; Katherine L Nathanson; Timothy R Rebbeck; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Jacek Gronwald; Tomasz Huzarski; Cezary Cybulski; Tomasz Byrski; Ana Osorio; Teresa Ramóny Cajal; Alexandra V Stavropoulou; Javier Benítez; Ute Hamann; Matti Rookus; Cora M Aalfs; Judith L de Lange; Hanne E J Meijers-Heijboer; Jan C Oosterwijk; Christi J van Asperen; Encarna B Gómez García; Nicoline Hoogerbrugge; Agnes Jager; Rob B van der Luijt; Douglas F Easton; Susan Peock; Debra Frost; Steve D Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Fiona Lalloo; Louise Izatt; Ros Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Andrew K Godwin; Harsh Pathak; Dominique Stoppa-Lyonnet; Olga M Sinilnikova; Sylvie Mazoyer; Laure Barjhoux; Mélanie Léoné; Marion Gauthier-Villars; Virginie Caux-Moncoutier; Antoine de Pauw; Agnès Hardouin; Pascaline Berthet; Hélène Dreyfus; Sandra Fert Ferrer; Marie-Agnès Collonge-Rame; Johanna Sokolowska; Saundra Buys; Mary Daly; Alex Miron; Mary Beth Terry; Wendy Chung; Esther M John; Melissa Southey; David Goldgar; Christian F Singer; Muy-Kheng Maria Tea; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Thomas V O Hansen; Bent Ejlertsen; Oskar T Johannsson; Kenneth Offit; Kara Sarrel; Mia M Gaudet; Joseph Vijai; Mark Robson; Marion R Piedmonte; Lesley Andrews; David Cohn; Leslie R DeMars; Paul DiSilvestro; Gustavo Rodriguez; Amanda Ewart Toland; Marco Montagna; Simona Agata; Evgeny Imyanitov; Claudine Isaacs; Ramunas Janavicius; Conxi Lazaro; Ignacio Blanco; Susan J Ramus; Lara Sucheston; Beth Y Karlan; Jenny Gross; Patricia A Ganz; Mary S Beattie; Rita K Schmutzler; Barbara Wappenschmidt; Alfons Meindl; Norbert Arnold; Dieter Niederacher; Sabine Preisler-Adams; Dorotehea Gadzicki; Raymonda Varon-Mateeva; Helmut Deissler; Andrea Gehrig; Christian Sutter; Karin Kast; Heli Nevanlinna; Kristiina Aittomäki; Jacques Simard; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Gail E Tomlinson; Jeffrey Weitzel; Judy E Garber; Olufunmilayo I Olopade; Wendy S Rubinstein; Nadine Tung; Joanne L Blum; Steven A Narod; Sean Brummel; Daniel L Gillen; Noralane Lindor; Zachary Fredericksen; Vernon S Pankratz; Fergus J Couch; Paolo Radice; Paolo Peterlongo; Mark H Greene; Jennifer T Loud; Phuong L Mai; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Anne-Marie Gerdes; Mads Thomassen; Uffe Birk Jensen; Anne-Bine Skytte; Maria A Caligo; Andrew Lee; Georgia Chenevix-Trench; Antonis C Antoniou; Susan L Neuhausen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-22       Impact factor: 4.254

9.  The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.

Authors:  O Porzio; M Federici; M L Hribal; D Lauro; D Accili; R Lauro; P Borboni; G Sesti
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

10.  Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.

Authors:  Susan L Neuhausen; Sean Brummel; Yuan Chun Ding; Christian F Singer; Georg Pfeiler; Henry T Lynch; Katherine L Nathanson; Timothy R Rebbeck; Judy E Garber; Fergus Couch; Jeffrey Weitzel; Steven A Narod; Patricia A Ganz; Mary B Daly; Andrew K Godwin; Claudine Isaacs; Olufunmilayo I Olopade; Gail Tomlinson; Wendy S Rubinstein; Nadine Tung; Joanne L Blum; Daniel L Gillen
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more
  14 in total

1.  The prognostic value of elevated ezrin in patients with osteosarcoma.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Zhao-Wan Xu; Li-Na Xu; Bin-Wu Wang
Journal:  Tumour Biol       Date:  2013-09-07

2.  Association of IRS1 Gly972Arg and IRS2 Gly1057Asp polymorphisms with gastric cancer in Turkish subjects.

Authors:  Gokhan Gorgisen; Ugur Karatas; Can Ates; Murat Oksuz; Ismail Musab Gulacar
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 3.  Association between NQO1 C609T polymorphism and prostate cancer risk.

Authors:  Zihan Sun; Yuling Cui; Jing Pei; Zhiqiang Fan
Journal:  Tumour Biol       Date:  2014-05-17

4.  Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility.

Authors:  Huanlei Wu; Jia Hu; Bo Liu; Yu Tao; Xiao Zhou; Xianglin Yuan
Journal:  Tumour Biol       Date:  2013-12-07

5.  The effects of genetic variants related to insulin metabolism pathways and the interactions with lifestyles on colorectal cancer risk.

Authors:  Su Yon Jung; Zuo-Feng Zhang
Journal:  Menopause       Date:  2019-07       Impact factor: 2.953

6.  Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2017-10-26

7.  Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.

Authors:  Peng Li; Lingjun Wang; Lihua Liu; Hong Jiang; Chong Ma; Tao Hao
Journal:  Tumour Biol       Date:  2014-04-03

8.  SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.

Authors:  Yanliang Hu; Zhifang Sun; Anhua Zhang; Jinjie Zhang
Journal:  Tumour Biol       Date:  2013-08-16

9.  Association between Single Nucleotide Polymorphisms in Gamma-Aminobutyric Acid B Receptor, Insulin Receptor Substrate-1, and Hypocretin Neuropeptide Precursor Genes and Susceptibility to Obstructive Sleep Apnea Hypopnea Syndrome in a Chinese Han Population.

Authors:  Zhijun Li; Tingyu Tang; Jianzong Du; Wenjuan Wu; Xiaoxi Zhou; Guangyue Qin
Journal:  Med Princ Pract       Date:  2016-08-10       Impact factor: 1.927

10.  Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.

Authors:  Su Yon Jung; Thomas Rohan; Howard Strickler; Jennifer Bea; Zuo-Feng Zhang; Gloria Ho; Carolyn Crandall
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.